Variant report
Variant | nsv1025586 |
---|---|
Chromosome Location | chr5:98574953-98625270 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:98571402..98573856-chr5:98574423..98577083,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs6596768 | chr5:98574953-98574954 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs551028379 | chr5:98574977-98574978 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs188163638 | chr5:98575083-98575084 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs374032677 | chr5:98575136-98575137 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs192914433 | chr5:98575150-98575151 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs548793080 | chr5:98575163-98575164 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs185127906 | chr5:98575174-98575175 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs34560849 | chr5:98575184-98575185 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs534255411 | chr5:98575191-98575192 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs140201678 | chr5:98575255-98575256 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs570790579 | chr5:98575257-98575258 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs562823659 | chr5:98575303-98575304 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs538216767 | chr5:98575349-98575350 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs546734886 | chr5:98575376-98575377 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs6863194 | chr5:98575406-98575407 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs116601319 | chr5:98575414-98575415 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs58349538 | chr5:98575433-98575434 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs374667960 | chr5:98575500-98575501 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs572625910 | chr5:98575596-98575597 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs116461099 | chr5:98575627-98575628 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs564979499 | chr5:98575632-98575633 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs532042334 | chr5:98575633-98575634 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs142265478 | chr5:98575655-98575656 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs563080732 | chr5:98575666-98575667 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs115393243 | chr5:98575667-98575668 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs151255683 | chr5:98575804-98575805 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs187923547 | chr5:98575816-98575817 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs139291808 | chr5:98575817-98575818 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs7716779 | chr5:98575821-98575822 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs570921642 | chr5:98575826-98575827 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs537891829 | chr5:98575987-98575988 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs550107318 | chr5:98575988-98575989 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs111655159 | chr5:98575992-98575993 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs567873068 | chr5:98575999-98576000 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs560193842 | chr5:98576058-98576059 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs538105215 | chr5:98576066-98576067 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs532435976 | chr5:98576070-98576071 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs7716153 | chr5:98576081-98576082 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs572736068 | chr5:98576090-98576091 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs147814193 | chr5:98576094-98576095 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs11956641 | chr5:98576112-98576113 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs73137714 | chr5:98576170-98576171 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs116684821 | chr5:98576210-98576211 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs192486686 | chr5:98576213-98576214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs7716477 | chr5:98576246-98576247 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs74403838 | chr5:98576276-98576277 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs183726673 | chr5:98576281-98576282 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs141340075 | chr5:98576327-98576328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs188093429 | chr5:98576420-98576421 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs180762993 | chr5:98576431-98576432 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16774939 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Prostate cancer | 16461572 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:98574200-98579200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr5:98576600-98577200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr5:98578800-98579600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr5:98579200-98582800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr5:98582800-98584000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr5:98583000-98583600 | Enhancers | Fetal Muscle Leg | muscle |
7 | chr5:98583400-98584200 | Enhancers | HUVEC | blood vessel |
8 | chr5:98584000-98584400 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr5:98584400-98584800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr5:98589400-98592400 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr5:98591200-98591800 | Active TSS | Primary T helper memory cells from peripheral blood 1 | blood |
12 | chr5:98592400-98593000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr5:98593000-98593200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
14 | chr5:98615200-98615600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
15 | chr5:98621600-98622000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |